Biofrontera Total Current Liabilities vs Other Stockholder Equity Analysis

BFRIW Stock

USD 0.06 0 1.69%

Biofrontera Warrants financial indicator trend analysis is way more than just evaluating Biofrontera Warrants prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Biofrontera Warrants is a good investment. Please check the relationship between Biofrontera Warrants Total Current Liabilities and its Other Stockholder Equity accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biofrontera Warrants. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy Biofrontera Stock please use our How to Invest in Biofrontera Warrants guide.

Total Current Liabilities vs Other Stockholder Equity

Total Current Liabilities vs Other Stockholder Equity Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Biofrontera Warrants Total Current Liabilities account and Other Stockholder Equity. At this time, the significance of the direction appears to have strong relationship.

The correlation between Biofrontera Warrants' Total Current Liabilities and Other Stockholder Equity is 0.71. Overlapping area represents the amount of variation of Total Current Liabilities that can explain the historical movement of Other Stockholder Equity in the same time period over historical financial statements of Biofrontera Warrants, assuming nothing else is changed. The correlation between historical values of Biofrontera Warrants' Total Current Liabilities and Other Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Liabilities of Biofrontera Warrants are associated (or correlated) with its Other Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Stockholder Equity has no effect on the direction of Total Current Liabilities i.e., Biofrontera Warrants' Total Current Liabilities and Other Stockholder Equity go up and down completely randomly.

Correlation Coefficient

0.71

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Total Current Liabilities

Total Current Liabilities is an item on Biofrontera Warrants balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Biofrontera Warrants are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Other Stockholder Equity

Most indicators from Biofrontera Warrants' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Biofrontera Warrants current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biofrontera Warrants. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy Biofrontera Stock please use our How to Invest in Biofrontera Warrants guide.At this time, Biofrontera Warrants' Tax Provision is fairly stable compared to the past year. Issuance Of Capital Stock is likely to climb to about 8.8 M in 2024, whereas Selling General Administrative is likely to drop slightly above 35 M in 2024.

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	540K	1.2M	1.1M	1.5M
Interest Income	16K	175K	168K	90.6K

Depreciation And Amortization Interest Income

Biofrontera Warrants fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Total Current Assets	Non Current Liabilities Other	Net Working Capital
Total Assets		-0.61	0.15	0.63	0.7	0.28	-0.74	-0.63	0.1	0.74	0.95	0.92	-0.18	0.8	0.41	0.39	-0.48	-0.77	0.67	0.71	-0.37	0.8	0.26	1.0	-0.63	0.71
Short Long Term Debt Total	-0.61		0.67	-0.35	-0.98	-0.52	0.96	0.85	-0.54	-0.33	-0.49	-0.56	0.47	-0.41	-0.11	-0.69	0.94	0.77	-0.66	-0.9	0.95	-0.52	-0.62	-0.62	0.57	-0.36
Other Current Liab	0.15	0.67		0.15	-0.54	-0.34	0.49	0.54	-0.69	0.34	0.28	0.21	0.56	0.34	0.32	-0.52	0.72	0.23	-0.32	-0.46	0.81	0.17	-0.51	0.13	0.18	0.26
Total Current Liabilities	0.63	-0.35	0.15		0.47	0.81	-0.34	-0.66	0.43	0.17	0.7	0.56	-0.37	0.37	0.83	0.75	-0.46	-0.09	0.29	0.71	-0.28	0.78	0.74	0.61	-0.92	0.09
Total Stockholder Equity	0.7	-0.98	-0.54	0.47		0.58	-0.97	-0.84	0.46	0.41	0.61	0.67	-0.4	0.53	0.27	0.7	-0.93	-0.78	0.61	0.92	-0.91	0.67	0.64	0.7	-0.63	0.43
Property Plant And Equipment Net	0.28	-0.52	-0.34	0.81	0.58		-0.38	-0.71	0.67	-0.19	0.36	0.25	-0.51	0.08	0.73	0.89	-0.72	0.03	0.1	0.75	-0.61	0.62	0.96	0.27	-0.84	-0.23
Net Debt	-0.74	0.96	0.49	-0.34	-0.97	-0.38		0.76	-0.31	-0.58	-0.6	-0.74	0.26	-0.62	-0.08	-0.57	0.83	0.9	-0.72	-0.86	0.84	-0.57	-0.47	-0.75	0.49	-0.61
Retained Earnings	-0.63	0.85	0.54	-0.66	-0.84	-0.71	0.76		-0.81	-0.09	-0.55	-0.46	0.76	-0.19	-0.34	-0.89	0.9	0.48	-0.68	-0.95	0.8	-0.56	-0.81	-0.64	0.88	-0.09
Accounts Payable	0.1	-0.54	-0.69	0.43	0.46	0.67	-0.31	-0.81		-0.5	0.06	-0.15	-0.95	-0.41	0.2	0.8	-0.72	0.04	0.34	0.63	-0.64	0.14	0.78	0.1	-0.72	-0.5
Cash	0.74	-0.33	0.34	0.17	0.41	-0.19	-0.58	-0.09	-0.5		0.64	0.89	0.48	0.94	0.01	-0.07	-0.05	-0.79	0.52	0.3	-0.05	0.46	-0.2	0.75	-0.03	0.99
Non Current Assets Total	0.95	-0.49	0.28	0.7	0.61	0.36	-0.6	-0.55	0.06	0.64		0.87	-0.17	0.78	0.63	0.33	-0.43	-0.62	0.42	0.63	-0.3	0.92	0.27	0.94	-0.65	0.58
Non Currrent Assets Other	0.92	-0.56	0.21	0.56	0.67	0.25	-0.74	-0.46	-0.15	0.89	0.87		0.15	0.95	0.37	0.32	-0.39	-0.79	0.58	0.65	-0.32	0.78	0.22	0.92	-0.46	0.86
Long Term Debt	-0.18	0.47	0.56	-0.37	-0.4	-0.51	0.26	0.76	-0.95	0.48	-0.17	0.15		0.41	-0.2	-0.64	0.64	0.01	-0.33	-0.53	0.54	-0.17	-0.6	-0.18	0.68	0.48
Cash And Short Term Investments	0.8	-0.41	0.34	0.37	0.53	0.08	-0.62	-0.19	-0.41	0.94	0.78	0.95	0.41		0.31	0.07	-0.21	-0.75	0.38	0.43	-0.18	0.71	0.0	0.8	-0.21	0.92
Net Receivables	0.41	-0.11	0.32	0.83	0.27	0.73	-0.08	-0.34	0.2	0.01	0.63	0.37	-0.2	0.31		0.43	-0.3	0.12	-0.23	0.4	-0.14	0.83	0.54	0.38	-0.69	-0.08
Common Stock Shares Outstanding	0.39	-0.69	-0.52	0.75	0.7	0.89	-0.57	-0.89	0.8	-0.07	0.33	0.32	-0.64	0.07	0.43		-0.8	-0.18	0.51	0.89	-0.7	0.46	0.97	0.4	-0.88	-0.09
Non Current Liabilities Total	-0.48	0.94	0.72	-0.46	-0.93	-0.72	0.83	0.9	-0.72	-0.05	-0.43	-0.39	0.64	-0.21	-0.3	-0.8		0.53	-0.47	-0.9	0.98	-0.55	-0.78	-0.48	0.7	-0.07
Inventory	-0.77	0.77	0.23	-0.09	-0.78	0.03	0.9	0.48	0.04	-0.79	-0.62	-0.79	0.01	-0.75	0.12	-0.18	0.53		-0.71	-0.59	0.57	-0.46	-0.04	-0.78	0.19	-0.83
Other Current Assets	0.67	-0.66	-0.32	0.29	0.61	0.1	-0.72	-0.68	0.34	0.52	0.42	0.58	-0.33	0.38	-0.23	0.51	-0.47	-0.71		0.68	-0.44	0.18	0.29	0.69	-0.44	0.54
Other Stockholder Equity	0.71	-0.9	-0.46	0.71	0.92	0.75	-0.86	-0.95	0.63	0.3	0.63	0.65	-0.53	0.43	0.4	0.89	-0.9	-0.59	0.68		-0.82	0.68	0.82	0.72	-0.85	0.3
Total Liab	-0.37	0.95	0.81	-0.28	-0.91	-0.61	0.84	0.8	-0.64	-0.05	-0.3	-0.32	0.54	-0.18	-0.14	-0.7	0.98	0.57	-0.44	-0.82		-0.43	-0.69	-0.38	0.53	-0.1
Net Invested Capital	0.8	-0.52	0.17	0.78	0.67	0.62	-0.57	-0.56	0.14	0.46	0.92	0.78	-0.17	0.71	0.83	0.46	-0.55	-0.46	0.18	0.68	-0.43		0.48	0.78	-0.71	0.4
Property Plant And Equipment Gross	0.26	-0.62	-0.51	0.74	0.64	0.96	-0.47	-0.81	0.78	-0.2	0.27	0.22	-0.6	0.0	0.54	0.97	-0.78	-0.04	0.29	0.82	-0.69	0.48		0.26	-0.84	-0.22
Total Current Assets	1.0	-0.62	0.13	0.61	0.7	0.27	-0.75	-0.64	0.1	0.75	0.94	0.92	-0.18	0.8	0.38	0.4	-0.48	-0.78	0.69	0.72	-0.38	0.78	0.26		-0.62	0.72
Non Current Liabilities Other	-0.63	0.57	0.18	-0.92	-0.63	-0.84	0.49	0.88	-0.72	-0.03	-0.65	-0.46	0.68	-0.21	-0.69	-0.88	0.7	0.19	-0.44	-0.85	0.53	-0.71	-0.84	-0.62		0.03
Net Working Capital	0.71	-0.36	0.26	0.09	0.43	-0.23	-0.61	-0.09	-0.5	0.99	0.58	0.86	0.48	0.92	-0.08	-0.09	-0.07	-0.83	0.54	0.3	-0.1	0.4	-0.22	0.72	0.03

Click cells to compare fundamentals

Biofrontera Warrants Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Biofrontera Stock Analysis

When running Biofrontera Warrants' price analysis, check to measure Biofrontera Warrants' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biofrontera Warrants is operating at the current time. Most of Biofrontera Warrants' value examination focuses on studying past and present price action to predict the probability of Biofrontera Warrants' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biofrontera Warrants' price. Additionally, you may evaluate how the addition of Biofrontera Warrants to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Biofrontera Total Current Liabilities vs Other Stockholder Equity Analysis

Total Current Liabilities vs Other Stockholder Equity

Total Current Liabilities vs Other Stockholder Equity Correlation Analysis

Correlation Coefficient

Total Current Liabilities

Other Stockholder Equity

Biofrontera Warrants fundamental ratios Correlations

Biofrontera Warrants Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Also Currently Popular

Additional Tools for Biofrontera Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Net Working Capital	+ 0.99	Cash
Total Liab	+ 0.98	Non Current Liabilities Total
Property Plant And Equipment Gross	+ 0.97	Common Stock Shares Outstanding
Net Debt	+ 0.96	Short Long Term Debt Total
Property Plant And Equipment Gross	+ 0.96	Property Plant And Equipment Net

Total Stockholder Equity	- 0.98	Short Long Term Debt Total
Net Debt	- 0.97	Total Stockholder Equity
Long Term Debt	- 0.95	Accounts Payable
Other Stockholder Equity	- 0.95	Retained Earnings
Non Current Liabilities Total	- 0.93	Total Stockholder Equity
Non Current Liabilities Other	- 0.92	Total Current Liabilities